Amid a backdrop of fluctuating global markets, with the Hang Seng Index recently experiencing a notable decline, investors are increasingly focused on stable income streams. In this context, high-yield dividend stocks in Hong Kong, such as Dawnrays Pharmaceutical Holdings, offer potential for both income and diversification in uncertain times.